Factors Other Than Low-Dose Computed Tomography Screening Related to Stage Shift and Improved Survival of Lung Cancer. Inagaki Y. J Thorac Oncol 2023;18:e48-e49.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Inagaki Y. Factors Other Than Low-Dose Computed Tomography Screening Related to Stage Shift and Improved Survival of Lung Cancer. J Thorac Oncol 2023;18:e48-e49.
PMID: 37087121